Extendicare Vs. Aligos Therapeutics Industry Stock Comparison

Buy

89

EXE.TO
Extendicare

Last Price:

10.63

Seasonality Move:

5.79%

Buy

74

ALGS
Aligos Therapeutics

Last Price:

32.60

Seasonality Move:

10.65%

Buy

89

Extendicare (EXE.TO) is a Buy

Is Extendicare a Buy, Sell or Hold?

The current Extendicare [EXE.TO] share price is $10.64. The Score for EXE.TO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
EXE.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

74

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EXE.TO Stock Price Chart

What is Extendicare's stock price today?

The Extendicare share price today is $10.64
The current trend is moderately bullish and EXE.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

EXE.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.28	Buy
Relative Strength Index (14 RSI):	65.73	Buy
Chaikin Money Flow:	109466	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.77 - 10.69)	Buy
Bollinger Bands (100):	(8.19 - 10.01)	Buy

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4.32	Buy
Relative Strength Index (14 RSI):	81.62	Buy
Chaikin Money Flow:	315379	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(14.3 - 26.46)	Buy
Bollinger Bands (100):	(7.85 - 19.03)	Buy

EXE.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.64	Sell
20-day SMA:	10.43	Buy
50-day SMA:	9.73	Buy
200-day SMA:	8.23	Buy
8-day EMA:	10.59	Buy
20-day EMA:	10.36	Buy
50-day EMA:	9.85	Buy
200-day EMA:	8.54	Buy

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	27.35	Buy
20-day SMA:	22.81	Buy
50-day SMA:	14.24	Buy
200-day SMA:	15.81	Buy
8-day EMA:	27.13	Buy
20-day EMA:	22.88	Buy
50-day EMA:	17.49	Buy
200-day EMA:	15.94	Buy

Extendicare Earnings Growth & EXE.TO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and a decrease next year of $0.11 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Extendicare Technical Analysis

	Nov 27	Nov 28	Nov 29	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10
	Nov				Dec
	27	28	29	02	03	04	05	06	09	10
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10
	Nov				Dec
	26	27	29	02	03	04	05	06	09	10
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):